Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults

an open-label trial (ANRS 165 Darulight)

Molina, Jean-Michel
Gallien, Sebastien
Chaix, Marie-Laure
El Abbassi, El Mountacer
Madelaine, Isabelle
Katlama, Christine
Valin, Nadia
Delobel, Pierre
Desseaux, Kristell
Peytavin, Gilles
Saillard, Juliette
Raffi, François
Chevret, Sylvie
Ponscarme, Dr D
Lascoux, Dr C
Girard, Prof. P M
Rami, Dr A
Yazdanpanah, Prof. Y
Simon, Dr A
Tubiana, Dr R
Duvivier, Dr C
Jeantils, Dr V
Loreillard, Dr D
Poizot-Martin, Dr I
Bernard, Prof. L
Gras, Dr G
Allavena, Dr C
Bernaud, Dr C
Bouchez, Dr S
Hall, Dr N
Reliquet, Dr V
Raffi, Prof. F
De Truchis, Dr P
Charreau, I
Bocquet, Dr L
Lemoing, Prof V
Point, G
Molina, Prof. J M
Chevret, Prof. S
El Abbassi, E M
Gallien, Dr S
Tattevin, Prof. P
Gras, Dr G
Chaix, Dr M L
Peytavin, Dr G
Saillard, J
Couffin-Cadiergues, S
Madelaine, I
Diallo, A
Gibowski, S

Department of Infectious Diseases, Saint-Louis Hospital, AP-HP, Paris, France
University of Paris Diderot, Sorbonne Paris University, Paris, France
Department of Immunology and Infectious Diseases, Henri-Mondor Hospital, Creteil, France
Laboratory of Virology, Saint-Louis Hospital, AP-HP, Paris, France
Department of Biostatistics, Saint-Louis Hospital, AP-HP, Paris, France
Pharmacy, Saint-Louis Hospital, AP-HP, Paris, France
Department of Infectious Diseases, Pitié Salpêtrière Hospital, Paris, France
Department of Infectious Diseases, Saint-Antoine Hospital, Paris, France
Department of Infectious Diseases, Toulouse University Hospital, Toulouse, France
Department of Pharmacology, Bichat Hospital, Paris, France
ANRS, Paris, France
Infectious Disease Department and INSERM CIC 1413, University Hospital of Nantes, Nantes, France

Corresponding author. Tel: +33142499066; Fax: +33142499067; E-mail: [email protected]

Members are listed in the Acknowledgements section.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/about_us/legal/notices)

Received March 01, 2018

Received in revised form April 14, 2018

Accepted April 17, 2018

Journal of Antimicrobial Chemotherapy 73(8):p 2129-2136, August 2018. | DOI: 10.1093/jac/dky181